Intermittent G-CSF in Patients With Breast Cancer Receiving Adjuvant Docetaxel, Doxorubicin, and Cyclophosphamide (TAC)

NCT02685111 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

22

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer
Neutropenia
Febrile Neutropenia

Interventions

DRUG: Filgrastim
DRUG: Peg-filgrastim

Sponsor

Asan Medical Center

Collaborators

[object Object]